Gene Technology: Describe the technology.

Assignment 2: Gene Technology
Paper , Order, or Assignment Requirements

Gene technology carries with it social and ethical implications—many of which engender personal views and discussion.
Select one (1) of the following biotechnology topics to write about:
• Genetically modified crop plants
• Genetically modified microorganisms
• Genetically modified animals
• Personal genomics and / or personalized medicine for humans
• Gene therapy
Write a four to six 4 page paper on your chosen topic. Organize your paper into sections corresponding to the following requirements:
1. Biological basis. Describe the technology. Discuss what it accomplishes. Elaborate on the scientific principles that make this technology possible. Your goal in this section of the paper is to show the instructor that you understand the underlying science behind the technology. Describe how exactly the technology works. Discuss the biological principles that underlie this technology.
2. Social and ethical implications. Without disclosing your personal view about this technology, provide an analysis of its social and ethical implications. State the ethical concerns apparent in the use of this technology. Discuss the benefits and risks. Your goal in this section is to look at all sides of the issue. In the next section, you will give your opinion.
3. Personal viewpoint. In the previous section, your goal was to be as objective as possible, to look at all sides of the issues. In this section, your goals are to give a personal opinion about the technology and provide a justification of that opinion.

 

"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"

What, if any, opportunities are there for cost control if the decision to merge with the physician group is made by the hospital?

The Pros and Cons of Mergers and Acquisitions
Paper , Order, or Assignment Requirements

Review the following scenario:
You are the chief executive officer (CEO) of a 200-bed nonprofit community hospital that serves a rural community with a population of 50, 000. The demographics include a median household income of $38,000. Currently, slightly less than half of the population (45%) has employer-sponsored insurance, with 35% having a combination of Medicare and private supplemental insurance and the remaining 20% being uninsured. The population is aging, with 40% of the population expected to reach Medicare eligibility age within the next 5 years, where employer-sponsored insurance will shift to Medicare or a combination of Medicare and other supplemental insurance.
A group of internal medicine physicians specializing in geriatric medicine, including joint replacement surgeries, is looking to expand their services. The physician group has approached the hospital about merging their services with the hospital and expanding the hospital to include an ambulatory care center and outpatient surgical center.
Based on your analysis of the scenario, explain the potential risks and benefits of the merger. Be sure to address the following:
• What, if any, opportunities are there for cost control if the decision to merge with the physician group is made by the hospital?
• What are some of the changes in Medicare reimbursement that could affect the long-term success of the merger?
• Would the community hospital be better served by countering the physician group’s offer to merge with the hospital or would acquiring the physician group better serve the hospital’s interests?
• Describe any ethical considerations that could influence the CEO’s decision.

 

"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"

Gene Technology:Examine DNA structure, and function, gene expression, and control.

Gene Technology:Examine DNA structure, and function, gene expression, and control.
Order instructions

Gene technology carries with it social and ethical implications—many of which engender personal views and discussion.

Select one (1) of the following biotechnology topics to write about:

Genetically modified crop plants
Genetically modified microorganisms
Genetically modified animals
Personal genomics and / or personalized medicine for humans
Gene therapy.
Describe the technology.
Discuss what it accomplishes.
Elaborate on the scientific principles that make this technology possible.
Describe how exactly the technology works. Discuss the biological principles that underlie this technology.
Social and ethical implications.
Provide an analysis of its social and ethical implications. State the ethical concerns apparent in the use of this technology.
Discuss the benefits and risks. Your goal in this section is to look at all sides of the issue.
Discuss the various applications of genomics and biotechnology.

 

"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"

Should our government be involved in controlling the price of this drug? Or, should the government force Glaxco to share the key knowledge of this product with its competitors (price becomes competitive)?

AIDS
Paper , Order, or Assignment Requirements

Let′s say for the past ten years, pharmacy X spent 90% of its R & D (research and development) on development of a drug that cures or slows down AIDS (Acquired Immunodeficiency Syndrome). Finally in 2010, the company launched its product under the protection of a patent right. Overnight, demand for the product grows tenfold as there are no alternatives to the medicine. As a result, Company X decided to charge a premium price that includes a handsome profit. For example, if the cost of producing a tablet is $5 then the company is charging $10 as its final price. Read the following sides: a) It is a risk taking venture from the perspective of a corporation. In the beginning, there is always a 50% chance of being unsuccessful of inventing anything new. It is important to consider opportunity cost of risk that a company takes while the same resources could be used to increase the company’s profitability by making a safer investment. As a result, our government gives incentives to individuals and corporations by providing them with the protection of patent rights. If we take this incentive away, individuals and corporations alike will have no reason to take risks to invent or create new things that could improve the future of the world. b) The objective of a publicly traded company is to make profit for its owners i.e. shareholders. However, there are millions of AIDS victims in this world. Most of these victims are from destitute countries, like African nations. It would be irrational for us to think that these people could afford this medicine at an existing market price. The world organizations, such as WHO (world health organization), provide with assistance by subsidizing AIDS related medicine. However, this is not enough as many people are dying every day. Many argue that this medicine should be free as it is the only way a victim’s life could be prolonged or saved. GlaxcoSmithKline already allows license for generic drug production to countries, like South Africa. Should our government be involved in controlling the price of this drug? Or, should the government force Glaxco to share the key knowledge of this product with its competitors (price becomes competitive)? Explain why or why not? What should be done in order to create an atmosphere where everyone (both business and victims) succeeds?

 

"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"

Is There a Cure for High Drug Prices?

Two Responses
Paper , Order, or Assignment Requirements

But, according to the Consumer Reports article, “Is There a Cure for High Drug Prices?”, the government already subsidizes about 38% of drug research in the form of grants. With these grants, I believe, should come stipulations on how the drugs are priced. This, in short, would involve coming up with a formula for the true cost of the drugs and an acceptable profit margin. The Consumer Reports article points out how the true cost of the drug may not be so straight forward. Production and distribution costs are simple enough, but research, marketing and advertising are a little more complicated. In my opinion, the government should determine about how much companies, on average spend on this, and come up with a constant that the companies can add on to the cost of production and distribution. From there, it’s a matter of deciding what profit margin most pharmaceutical companies will find acceptable. Also, the BBC’s “What’s a Fair Price for a Drug” reports that Turing Pharmaceuticals claims to have a program in place where people who cannot afford an expensive drug can get it for free. I think programs like these are great and should be encouraged and verified. That is, they should be incentivized, perhaps in the form of grants, and overseen to make sure they are functioning properly and not leaving anyone behind. I also liked an idea in the Consumer Reports article. Basically they suggest opening up foreign trade in pharmaceuticals with reputable sources in Canada and Europe. This would increase the supply of medical drugs by increasing completion and hopefully lower prices overall. Discussion two: In a quick summary of my entire sentiment: The medical industry should not be privatized or profited by any industry period. Health care, along with education, should be out of the hands of capitalists and in the control of government care. The profits of a few, at the expense of many is obviously a trait of any free market, especially with the growth of trade capabilities in this global market, but aspects of public welfare should be protected by the nations that govern them. In this scenario Pharmacy company X has spent 90% of its profits on research and development. Although it makes sense for a company to want to maximize its profits in order to make up for the opportunity cost, there are clear moral complications. In an idealistic situation, the government would provide and pay for the employees, the scientists, the facility and ultimately the research and development of the medicinal products and services themselves. Therefore making the need for making justified profit unnecessary. The idea that a medicine′s price needs to be justified in order to satisfy the market is an immoral decision and comes with poor understanding of the community and or a poor moral compass Pharmaceutical industry leaders like Martin S. corrupt the very nature of the products they are claiming will heal civilians. They hide behind the idea that excess profits will only help and further research and development. There is also the idea that increasing the price will create a market of competitors that will ultimately lower the price. The collateral damage of such a long term solution will only continue to take it′s toll on the consumers. Again the pharmaceutical leaders are all ultimately hiding from the reality of the situation. The fruits of scientific development in health care should not be exclusive to the highest building industry. Although economists as well as most business professionals may find themselves in crossroads with ethics at some point in time, you can only hope that the decision wont effect millions.

 

"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"

Discuss the principles of holistic care and the four principles of the holistic caring process

Project Summarization
Paper , Order, or Assignment Requirements

submit a completed final project, in the form of a scholarly paper,

• Discuss the principles of holistic care and the four principles of the holistic caring process
• Discuss the differences in patient needs when developing a holistic plan of care
• Discuss the similarities and differences between complementary and alternative medicine and western medicine
• Describe the role of nutrition, exercise, humor and music therapy in complementary and alternative medicine
• Discuss three main barriers to changing our current healthcare system to a more integrative system of care
• Create a short summary of the case file (age, sex, diagnosis)
• Complete a comprehensive, review of needs or problems discovered, and provide rationales and interventions to address the needs
• Discuss implementation and evaluation of complementary and alternative modalities within the plan of care
• Write a short summary in 2–3 paragraphs about the highlights of what this course added to your professional practice and the way you will practice nursing in the future

 

"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"

What positioning do you recommend Yue Sai have in China?

summary
Paper , Order, or Assignment Requirements

L’Oreal in China: Marketing Strategies for Turning Around Chinese Luxury Cosmetic Brand Yue Sai

Best Marketing Case

AFM-CCMP Competition 2014

Maybe it was that eighth glass of baijiu that he had downed to show respect to the department store manager and her team, or their joke that they were honoured to see him but hoped that the head of Lancôme would join him at their next meeting, but all of a sudden doubts assailed Stéphane Wilmet, the new general manager of Yue Sai. Stéphane had always been passionate about China – teaching himself Chinese as a teenager – and had looked forward to coming back to China after an assignment with L’Oréal USA. But the challenge ahead was enormous. Yue Sai was one of the very few brands that had managed to lose volume and money in China’s booming cosmetics market – a sore point for L’Oréal. While politely engaging in small talk with his hosts about the superiority of the local cuisine, Stéphane’s mind kept returning to what was needed to turn around the situation and strengthen L’Oréal’s reputation in China.

The Chinese Cosmetics Market

Brief Overview

China has one of the world’s oldest civilizations with a history dating back 5,000 years, and is the most populous nation on the planet with over 1.3 billion people. Thanks to its consistently rapid economic development since the late 1970s, it is now the world’s second largest economy in terms of GDP (see Exhibit 1). The World Bank has projected that it will surpass the United States as the world’s largest economy in the coming decades. Given an enormous increase in disposable income, Chinese consumers increasingly desired more sophisticated, premium products in many categories, including beauty and skincare.

Procter & Gamble was the first multinational to enter mainland China’s beauty and skincare market, with Olay in 1989. With the exception of Estée Lauder which waited until 2002, the other multinationals quickly followed: Shiseido in 1991 with Shiseido, L’Oréal in 1997 with L’Oréal Paris, and Unilever in 1998 with Hazeline. They introduced extensive portfolios of high-quality brands and products, and brought marketing expertise, financial resources and cutting-edge R&D (which were soon localized by establishing local research centres). Initially, they drove out weak local brands, replacing them in the most desirable department stores.

As of 2010, the top five companies in the beauty and skincare market (including personal care) were all multinationals: P&G, L’Oréal, Shiseido, Unilever and Amway. Yet they still only accounted for 40% of the €18 billion market, and now had strong local competition. Firms such as Shanghai Jahwa and Jala had experienced extremely strong growth and their brands were available everywhere, from high-end department stores to local cosmetic stores, presenting a formidable challenge.

Specificities of the Chinese Cosmetics Market

Distribution Channels

When multinationals first entered China, premium cosmetics were almost exclusively distributed via department stores (see Exhibit 2). As in department stores worldwide, brands rent floor space and sometimes pay a sales-based commission to the department store. They are then free to create a store-within-a-store (or counter), staffed with their own beauty

assistants, with total control over sales and merchandising (but not, by law, on price). A legacy of the absence of other channels is that, even today, mass-market brands like L’Oréal Paris, Maybelline and Olay have counters in department stores in tier-2 and tier-3 cities (see Exhibit 3). In 2010, there were over 4,000 department stores in China, with a minimum of 6,000 m2 of retail space. They were stratified into three classes: class-1 stores carrying brands like Lancôme, Chanel and Dior were only present in the largest cities. Hefei, the capital of Anhui Province, a city with 5.7 million people and the world’s fastest growing metropolitan economy,1 only had a class-2 department store.

The second distribution channel consisted of beauty store chains like Watsons and Manning (see Exhibit 4). These employed their own beauty assistants who could sell any brand, but they also had smaller spaces dedicated to mass-market brands like L’Oréal Paris, Olay and Vichy, with assistants employed by the brands in the largest stores. The positioning of the LVMH-owned Sephora chain is more upscale, allowing it to carry brands like Estée Lauder and Lancôme (and, of course, Dior). The third channel consisted of countless small local cosmetics stores selling exclusively beauty and personal care products without the help of beauty assistants (see Exhibit 5).

New channels of distribution, such as TV-based direct selling and ecommerce portals were rapidly emerging. Over half a billion Chinese consumers had access to the internet. Traditional media (e.g., TV, newspapers) were losing their appeal as the younger generation spent a significant portion of time texting, surfing the web, and using social media such as Weibo (a Chinese fusion of Twitter and Facebook). Internet-based retailing was thus likely to have a significant impact on existing channels in the near future.

Attitudes to and Usage of Cosmetic Products

For decades, cosmetics were seen as “counter-revolutionary” and were virtually non-existent in China. Generations of Chinese women grew up without ever learning about cosmetics from their mothers. This absence of inter-generational norms meant that cosmetic companies— starting with Yue Sai in 1992—had first to educate Chinese consumers about beauty products and routines. But it also created a market of open-minded consumers free of the preconceptions prevalent in many countries: for example, Chinese men were more open to skincare than their European and American counterparts.2 China alone accounted for 70% of the worldwide sales of the Men Expert line of L’Oréal Paris. Chinese women were less interested in colour cosmetics than Europeans or Americans, not to mention Japanese and Korean women, who have the most sophisticated beauty routine in the world.

Only 10-15% of the beauty products sold in the Chinese market were makeup products. Many Chinese women viewed makeup as superficial, unnecessary and potentially harmful to skin, and heavy makeup as socially undesirable. The perfume market was tiny in China. Perfumes were more often bought as gifts than actually used. China was therefore primarily a skincare market (as can be seen by the relative space devoted to skincare and makeup at Sephora in Exhibit 4). In China, the younger generation was significantly more receptive to cosmetics products than older consumers. The average cosmetics consumer was in her mid-20s (vs. early-50s in Europe). Most were raised as an only child (or “little emperor”), had significant disposable income, and liked novelty. For them, another “generation” meant people who did not overlap at university or were separated by a decade at most (not parents and children). Whereas European and American women associated a brand’s longevity with heritage and prestige (particularly for luxury brands), ‘old’ had negative associations among Chinese consumers.

Paradoxically, in parallel with the Chinese focus on novelty, there was a renewed interest in China’s ancient history, traditions and cultural heritage. Popular computer games and television shows were set in ancient China. Cultural beliefs pertaining to food, health and medicine had never been lost, and held true across all age groups.

Most Chinese have some knowledge of traditional Chinese medicine (TCM; ) and apply its basic principles, if only because they feel it could do no harm. TCM refers to a wide range of ancient medicinal practices, including herbs, acupuncture and massage, to prevent and treat ailments and enhance health. Common ingredients such as glycyrrhiza uralensis (), lonicera japonica (), “silver ear” mushrooms () and wolfberry () can be purchased in most grocery stores and are cooked with food or made into tea. Other more specific and expensive ingredients (TCM has over 1,800 ingredients) like angelica (), cordyceps (), ginseng (), and notoginseng () are typically bought in special TCM pharmacies (see Exhibit 6).

However, China’s economic development and rapid urbanization had come at a price. The country’s environment had deteriorated significantly and a large number of Chinese cities suffered from smog and polluted air and water, prompting a growing number of consumers to use skincare products to protect their skin. The pitfalls of industrialization and some high- profile food safety scandals (e.g., melamine-adulterated milk) had also boosted demand for products made with natural ingredients.

Rising Chinese Confidence

Chinese consumers were irresistibly drawn to Western brands in the 1990s and 2000s. Even today, a significant number of Chinese and Asian cosmetic brands uses French-sounding names (like Franic, Kosé, Laneíge and Mamonde). Consumers began to take an interest in Japanese cosmetics from companies like Shiseido (and its China-only brands like Aupres and Urara), which were perceived to be more knowledgeable about Asian skin and beauty, although historical animosity toward Japan and recent geopolitical tensions were a risk for Japanese brands.

Achievements such as sending astronauts into space, hosting the Olympic Games (Beijing 2008) and the World Expo (Shanghai 2010), building bullet trains and advanced planes, and the global success of firms like Haier, Huawei and Lenovo had made Chinese consumers increasingly proud of their nation. This had kindled an interest in products with a local heritage as well as boosting preference for domestic brands. For example, the 2008 launch of Shang Xia ()3, a Shanghai-based sub-brand of Hermès focused on furniture and decorative objects showcasing Chinese heritage and craftsmanship, was seen as a milestone in the rise of Chinese luxury brands. More generally, the reputation for quality, safety and the perceived R&D capabilities of Chinese firms had improved. This was particularly true of cosmetics, because many (including the international brands) were manufactured in China. Still, since most Chinese continued to associate luxury with foreign brands, it was unclear how quickly they would accept Chinese luxury brands.

Overall, Chinese consumers, especially those in the tier 1 cities like Beijing and Shanghai, were increasingly sophisticated about brands and products in the beauty and skincare categories. With more opportunities to shop abroad and wider access to information on international fashion trends, they could distinguish true premium brands from those simply aspiring to be perceived as such. A seemingly Western name and image were no longer enough to attract discerning Chinese consumers.

L’Oréal China

The Group

L’Oréal is the world’s largest cosmetics company, with worldwide sales of €19.5 billion in 2010. In that year, its sales in China exceeded €1 billion for the first time, an 11.1% increase over the previous year and a double-digit gain for the 10th consecutive year, making China the third-largest market for L’Oréal after the United States and France (vs. its seventh-largest in 2008). L’Oréal had vowed to acquire one billion new customers globally in the next decade, a significant portion of which will come from China.

L’Oréal is the second largest beauty and skincare player in China after P&G and No.1 in the luxury segment. It is present in China with almost all of its major brands, with the exception of Body Shop because Chinese regulations require cosmetics to be tested on animals. Five of its brands, including Lancôme and Maybelline New York, are No.1 in their respective categories.

The Luxury Product Division (LPD) manages premium brands such as Lancôme, Biotherm, Helena Rubinstein, Kiehl’s, Shu Uemura and Giorgio Armani. The Consumer Product Division (CPD) oversees brands such as L’Oréal Paris, Maybelline New York and Garnier. Other divisions oversee dermo-cosmetic brands (e.g., Vichy) and brands tailored for professional hair salons (e.g., Matrix).

L’Oréal has established a Research and Innovation Centre in Shanghai, and has manufacturing centres in Suzhou and in Yichang, where it produces most of its mass and professional brands. Luxury brands, with the notable exception of Yue Sai, are still imported. Yue Sai

Madam Yue-Sai Kan and the Pre-L’Oréal Years (1992-2004)

The first modern cosmetics brand of China, Yue Sai, was founded in 1992 by Madam Yue-Sai Kan,4 an Emmy-winning TV host, socialite and entrepreneur (see Exhibit 8), with the aim “to create, produce and sell the very best beauty and skincare products that we can offer to Asian women and to the world, and become the first global cosmetics brand from China.” Her key insight was that the standards of beauty in China were different from those of other cultures; there was no reason why Chinese women had access only to foreign products that had not been designed for their specific type of skin and beauty.

To promote the brand, Madam Yue-Sai Kan wrote the first book about makeup ever published in modern China, which became a huge best-seller. Battling myriad obstacles and local regulations, she secured distribution in department stores nationwide, personally trained China’s first beauty advisors, and developed a range of red lipstick and basic skincare products designed for Asian skin. The brand’s red lipstick became an icon in China.

In 1996, Madam Yue-Sai Kan sold the company to Coty, the New York-based cosmetics firm and world’s largest producer of fragrance, which outbid L’Oréal. Coty pushed the distribution of Yue Sai to reach more cities as well as less premium cosmetic stores. By 1998, Yue Sai had become the No.1 luxury cosmetic brand in China. Coty continued to focus on distribution rather than branding, and started focusing on its own brand, Lancaster. Yue Sai gradually lost relevance, straining the relationship between Coty and Madam Yue Sai.

L’Oréal acquired Yue Sai in 2004. L’Oréal CEO, Jean-Paul Agon, declared that adding an established Chinese brand like Yue Sai alongside European brands like L’Oréal Paris, American brands like Maybelline New York, and Japanese brands like Shu Uemura fitted perfectly with L’Oréal’s “beauty for all” mission. That same year, L’Oréal also acquired Mininurse, a Chinese brand targeted at the mass market. Given the enormous potential of the Chinese market, coupled with L’Oréal’s stellar track-record at integrating and developing brands (24 of its 27 major brands were obtained through acquisitions or licensing deals), the future looked bright for Yue Sai under L’Oréal management.

The Consumer Division Years (2004-2006)

The post-acquisition years were less smooth than anticipated. On the positive side, L’Oréal had acquired a brand with a wide distribution (more than 1,000 stores across different channels), strong sales (€39 million in 2006), historical strength in makeup, a few good skincare products and packaging, and a factory and R&D facility. On the other hand, the brand was associated with older consumers, sales were fading, it had lost its marketing and R&D innovative edge, and it was unclear how it fitted into L’Oréal’s brand portfolio in China.

Because Yue Sai had such a wide distribution and a moderate price, it was first assigned to the consumer-product division (CPD) of L’Oréal China. CPD tried to apply the marketing strategy that had proven so successful worldwide for L’Oréal Paris, a mix of scientific improvements, celebrity-driven glamour and wide accessibility. Yue Sai was priced slightly below L’Oréal Paris, new products were launched annually, and the brand continued to be distributed in a variety of channels. Communication focused on technology, featured beautiful Chinese actresses and models (see Exhibit 9), and was inspired by the L’Oréal Paris ads (see Exhibit 7).

The Luxury Division Years (2006-2010)

But the “Chinese L’Oréal Paris” strategy did not produce the intended results and the brand lost sales and awareness, while at the same time L’Oréal Paris was booming (see Exhibit 15). To provide the brand with a new strategy and new set of eyes, Yue Sai was transferred from the CPD division to the smaller Luxury Product Division (LPD) in 2006. LPD immediately promoted Yue Sai featuring a famous Taiwanese movie star, Shu Qi (), to re-establish the brand’s luxury image (see Exhibit 10).

To deliver Yue Sai’s longstanding brand promise that “Nobody knows Chinese skin better than Yue Sai,” L’Oréal’s Shanghai Research and Innovation Centre focused on creating products specifically designed for Chinese skin. For example, the Vital Essential line () launched in 2007 incorporated extract of ganoderma mushroom (), a traditional Chinese medicine ingredient believed to foster internal balance and boost internal energy, with a fragrance evocative of the distinctive smell of traditional pharmacies. This product was the most-liked of the Yue Sai line-up, with above-average repeat purchase scores.

LPD then hired a reputable Paris-based branding agency and together they chose to reposition Yue Sai as “the first brand to stand for Chinese women’s beauty”. They built on the insight that modern Chinese women were radically changing, were proud and self-confident, and had a clear vision of their future and their new role in society. Although they treasured their families, they wanted to build for themselves a new professional, artistic and cultural environment.

To communicate the new “modern Chinese women” positioning, L’Oréal invested in a major television and print advertising campaign featuring Chinese supermodel Du Juan (). These ads used such lifestyle taglines as “I hold my future in my hands” () and “I look forward to every day with confidence” (,) to bolster the image of Yue Sai as the brand for modern Chinese women (see Exhibit 11 and Exhibit 12). Consistent with the new positioning, Yue Sai’s prices were notched higher than L’Oréal Paris.

LPD tried to compensate for the volume decline brought by higher prices (see Exhibit 14) by entering new distribution channels such as Sephora (see Exhibit 16), while pushing for better deals with distributors in order to enter more cosmetic stores. Meanwhile, the increasing number of foreign premium brands entering the Chinese market led department stores to push Yue Sai’s counters further back in the stores, reducing their visibility and exposure to traffic. Some department stores even delisted the brand.

Turning Around Yue Sai

Alexis Perakis-Valat, who became CEO of L’Oréal China in 2010 at the age of 39, had big ambitions. He wanted to make L’Oréal the No.1 cosmetics firm in China, and turn China into L’Oréal’s No. 1 market by continuing to push into smaller cities and introducing L’Oréal’s luxury brands, including Kiehl’s and Yves Saint Laurent.

Yue Sai’s lacklustre performance was spoiling the picture. Despite a booming market, it had never turned a substantial profit and sales had barely improved (€35 million in 2010 vs. €31 million in 2005). In Alexis’ own words, it was “the pebble in L’Oréal’s shoe”. Internally, it was becoming difficult to motivate talent to work on the brand. Externally, it blemished L’Oréal’s reputation as a masterful integrator of acquired brands and companies, which could hamper L’Oréal’s future acquisition endeavours.

Alexis and Stéphane, with the help of Ronnie Liang, Yue Sai’s new marketing director, needed to move fast and on all fronts.

Strategic Decisions

Choosing the Right Value Proposition

When it was launched, Yue Sai was the uncontested premium Chinese brand. But today’s competitive landscape was very different. Yue Sai was not perceived as aspirational, unlike foreign brands such as Lancôme, Estée Lauder and Shiseido. It had an uncertain business model, an ageing consumer base, and an unclear positioning, the result of several years of trying various platforms. Yue Sai was not even the only Chinese brand owned by a large multinational company. Aupres (), a Shiseido brand launched in 1994, was developed specifically for and only available in Chinese department stores (see Exhibit 13), and had acquired a reputation for quality and a specific knowledge of Asian skin. The brand had been well managed and sales were around €100 million. There were indications that other multinationals would launch China-specific brands.

Chinese firms were catching up with the multinationals. Shanghai-based Jahwa group had recently launched Herborist () which already had sales of €70 million (up from €45

million in 2008) and was available at Sephora in both China and Europe. Its positioning was “blending traditional Chinese herbal medicine with modern biotechnology”. Herborist was unique in that it was distributed in department stores but also in small freestanding beauty stores which offered massage and spa treatments. Another Chinese mass-market brand, Chcédo5 (, owned by the Jala group) reached €165 million in sales in 2010. Its positioning was “Chcédo makes women blossom with natural beauty and charm.”

Given the situation facing Yue Sai and the current portfolio of brands of L’Oréal China, the critical issue is whether the brand should: 1) keep its new lifestyle positioning as the brand of “confident, modern Chinese women”, 2) be positioned as a Chinese luxury icon symbolizing the nation’s long history and rich heritage, 3) adopt a more affordable value proposition, or 4) try something totally different.

To choose the right positioning for Yue Sai, it is essential to decide which aspects of the brand should be retained and which should be discarded. For example, Yue Sai must decide whether to make its association with the L’Oréal group explicit to consumers by becoming a sub-brand (e.g., “Yue Sai by L’Oréal”) or by acknowledging L’Oréal’s ownership (e.g., by adding the tagline “Yue Sai, a Chinese brand of L’Oréal”).

Finally, Stéphane and Ronnie need to decide if they should follow Aupres, which has entered the Malaysian market, and expand Yue Sai internationally (but where?) Alternatively, should they consider extending the brand into other product categories (which ones?) or target other consumer segments (which ones)?

Marketing Mix Decisions

Advertising and Promotion

An important decision is whether to continue with the current TV and press campaign or to change it, at a time when media costs are climbing steadily and deteriorating sales limit the advertising and promotion budget. As more and more Chinese brands are relying on celebrities (actresses/actors, singers, athletes), should Yue Sai replace Du Juan with a celebrity or should they stay with a model? At the moment, 80% of Yue Sai’s communication budget is focused on skincare and 20% on makeup. Should this be changed? Further, should they change the current media plan or focus more on new media platforms like Weibo?

More generally, they need to determine what resources to allocate to brand communication vs. improving in-store presence, improving the product line-up, or changing distribution channels.

Pricing and Distribution

Stéphane and Ronnie must decide how Yue Sai should be priced within L’Oréal’s brand portfolio in China (especially in comparison with L’Oréal Paris). And whether all of Yue Sai’s products (see Exhibit 17) should be priced similarly, or should they charge more for some lines (which ones?)

One of the most important decisions will be to select the right channels of distribution based on the market tier(s) Yue Sai should pursue and the consumers it should target. How should Yue Sai deal with new distribution channels such as ecommerce portals? Should it engage in franchising to create its own stand-alone stores like Herborist?

Read the case, then answer the questions by paragraph.

What positioning do you recommend Yue Sai have in China? What are the pros and cons of a lifestyle positioning compared to a more concrete positioning on functional benefits? Who should be Yue Sai’s targeted customers?
Should Yue Sai be an independent brand, or should it be linked in any way to Loreal brand? Why?
How will you choose the price, promotion (objectives, message, mix of promotion methods), product (formulation and packaging), and distribution that will allow Yue Sai to reach both short-term and long-term goals?

 

"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"

Define the relationship between visionary leadership, emotional intelligence, and employee motivation.

Leadership, Mission, Vision, and Culture
Paper , Order, or Assignment Requirements

Course Outcome

HS450-1: Assess the impact of leadership, mission, vision, ethics and culture on the foundation for strategic planning

Unit Outcomes

• Define the relationship between visionary leadership, emotional intelligence, and employee motivation.

• Examine the concepts of ethics and cultural diversity for effective leadership in strategic management.

PC-4.3: Apply concepts of multiculturalism and diversity to become a change agent.
Instructions

Assessing and improving employee motivation are essential for effective strategic management. These skills can promote improved job satisfaction and overall productivity for successful outcomes in strategic planning for healthcare organizations. In order to properly assess motivation and satisfaction, a leader must be able to understand the needs and interpret the emotions of employees from diverse cultural backgrounds. This is referred to as emotional intelligence, which involves a sensitivity to and understanding of human expressions. (Human expressions can include facial expressions, body language, verbal communication, etc.)

Conduct searches in the Kaplan Library (http://library.kaplan.edu/onlinelibrary) for journal articles that address the topics of emotional intelligence (EI) and leadership. Then, go to the internet and conduct a search for “free emotional intelligence test.”
After completing your EI test, answer the following questions:
1. How does EI differ from traditional conceptions of intelligence?
2. After completing the emotional intelligence test, do you think that emotional intelligence can be “learned?” Do you see value in focusing on working to increase your emotional intelligence? Why or why not? (To answer this question, apply the findings from your EI self-evaluation.)

3. Is there a relationship between EI and leadership, between EI and motivation? How would you define those relationships?
4. Have you worked for a manager that you think exhibited a high degree of EI? Conversely, have you worked for a manager that exhibited a low level of EI? What was the impact of this manager(s) on your own motivation, productivity, and job satisfaction? Do you think the manager’s EI was beneficial when interacting with employees from culturally diverse backgrounds? Provide specific examples to explain the effects on cultural diversity in the workplace.
Unit 2: Assessing Operational Needs in the Health Care Setting – Discussion

Topic: Integrated Practice and Balanced Scorecard
Answer all of the following questions:
1. The evidence suggests that integrated physician practices use more evidenced-based care processes, provide more preventive health services, and offer more health promotion programs for the populations they serve than non-integrated practices. Medical groups involve physicians practicing exclusively as either salaried employees of the group or as partners. What are some reasons why these integrated practices may or may not be the most efficient ways to practice medicine considering the challenges facing health care organizations in the 21st Century?
2. What is the purpose of a balanced scorecard? How is the balanced scorecard used to lead and manage an organization?
3. How can the balanced scorecard be linked to organizational effectiveness as well as individual performance evaluation?

 

"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"

Does the very nature of conducting clinical trials in developing countries make it unethical?

Science Short Answers
Paper , Order, or Assignment Requirements

1. Does the very nature of conducting clinical trials in developing countries make it unethical? Identify the various stakeholders involved in such clinical testing and the reasons they use to defend or oppose such trials. Clearly state why and why not these clinical trials are ethical. Use examples from the article you have located and the assigned readings as supporting evidence. Look at both the individual’s needs and best interests and those of the community, and those who will ultimately benefit from this new drug/vaccine/device.What changes would you recommend to make this process of international clinical trials more transparent, equitable and more strictly regulated? Who should do/oversee the regulating? How do you envision your suggestions being enforced?
2. Is the case strong enough to recommend discontinuing all animal research? Why or why not? Explain your response and provide specific factors (time, events, new information, etc.) that may influence you to change your position.
3. Genetic engineering will transform our world in the next decade and is in fact already irreversibly altering our world. What do you think of Dr. Doudna’s call for a pause in using CRISPR technology in a clinical setting? Is this a good idea, why or why not and how would the world enforce this moratorium? The intersection of biotechnology, genetic engineering and bioethics is a constantly shifting landscape. What are the ethical considerations that these scientists need to be addressing?
4. Read and answer the following questions. http://eds.b.ebscohost.com.vlib.excelsior.edu/eds/detail/detail?sid=93ceaddf-2999-4ec7-852e-b0bd3350ec18%40sessionmgr102…
1. Select one of the seven fundamental unsolved questions
2. In your own words, explain this fundamental, unsolved question
3. Now do some research using the EC Library and/or Google Scholar to determine if this is STILL a question or if there is some newer research that addresses this concern.
4. Describe the results of your research – is there now an answer? Has the question changed? Is there a partial resolution or no change at all?
5. RE-write the question, either as a new question, a lingering question or a solution.
6. Use APA style referencing and in-text citations to identify at least two research article you have used in your work on this discussion post.
5. Identify two natural science disciplines and explain how the central dogma of one impacts the other. Explain how you see changes in this dogma/core theory is now affecting research and discoveries in the other discipline.
6. Select an important recent discovery from those you have read about or researched especially in the emerging fields. We will be using the term “discovery” in a broad sense, research the interdisciplinary fields and you will find plenty of “discoveries”.
• Identify and explain the discovery you are going to be examining
• Clearly indicate the two (at least) fields of the sciences that have enabled the researchers to make this discovery.
• Show how each field impacts the research in the other. What did they each bring to the research to enable this discovery?
• Explain how a more traditional scientific approach may have not allowed the same depth and breadth of discovery, but the integration of fields has lead to more creative and expansive research opportunities.
7. The braking down of silos and bridging of theories has accelerated the growth of discoveries and brought interdisciplinary researchers into the forefront of the “new sciences”. Select one new interdisciplinary science and describe and define its area of study.
8. Select one developing or underdeveloped country from the Eastern Europe, Central or South America, Asia or Africa. Use these web sites to identify your country. Please try to select a variety of places. The discussion will be dull indeed if we all select Brazil or China! Your instructor may award extra points for selecting a more obscure location!
• Least developed countries: UN classification
• List of Developing Countries from the International Statistical Institute
• What are its natural resources? This can include fresh water, arable land as well as things like coal, diamonds, oil, minerals (the rare earths are extremely important to technology products)
• What are the ecological/environmental l challenges? deforestation, desertification disappearing species, loss of biodiversity, pollution to water, air and soil, impact of climate change such as rising sea levels etc.
• What is being done and by who to protect the environment, repair the damage, stave off the effects of climate change or address the items you found in # 2
• What is being done to allow the country to benefit from its resources in a responsible way? By who? (this maybe the U.N., developed countries, or NGO’s)
9. Visit the following web site and read the information available there. Scroll down through the left side menu and select “Documents and Resources”. Follow this to “Documents” then select “Publications” then select “New Perspectives”. These are brief publications about the activities of this UN Environmental Program. Select one of the perspectives publications, open it and read it.
• Indigenous Peoples And Their Communities (UNEP)
For your initial post write a short summary of the issue you read. Tell us what is the concern discussed in this issue of the publication. How were indigenous people impacted by this and what were the solutions proposed?
10. First visit the EPA, The United States Environmental Protection Agency, “Climate Impacts” web page and read the information posted on this page.
Then select one sector either a location such as the Coasts or a concern such as Human Health. Read all the information on this topic. Each topic will have several links listed under the title such as: Climate Impacts on Coastal Areas
Be sure to follow each link and gather the information available on that topic. Next you should be examining efforts to address climate change. Go to the “Adapting to the Impacts of Climate Change, Report in Brief” (a report from the National Academies of Science, Engineering and Medicine) to examine the efforts being made to help communities and regions adjust to the this “new normal” as the impacts of climate change are being realized. You can read this report on the web site but if you want to download a pdf of the report you will need to sign-up, giving your name, email and creating a password. This is optional. This site also has related reports that maybe helpful in your research.
Do additional research on solutions suggested or tried for your topic. Include:
• Post the location, region or concern you selected in the title of your initial post.
• Create a clear organized and complete summary of the climate impacts on your selected topic, area etc.
• Discuss the worst case and best case scenarios predicted for this topic.
• Discuss the possible solutions or adaptations you have found
• Discuss the additional research information you have located and how this supports the EPA efforts or goes in a different direction and why
• Evaluate these possible solutions and the pros and cons of each
• In your opinion do you see any of these proposals as a viable solution; why or why not? Support your response with information from the research you cited.
11. Futurist – this always seemed like the best job in the world. You got paid to read, watch movies, surf the web and think about what could be the next big thing or what life will be like long after we’re gone. Nobody could ever actually hold you accountable for your predictions, they were just predictions after all, a best guess. This is your chance to try your hand at being a futurist for the natural sciences. We have seen two videos that focus on the disruptive nature of social media. As Clay Shirky says “Each of us is simultaneously an individual person and a global publisher.” When considering his observations on social media and those on the scientific community described by Michael Nielson, please think about where you see the future of the natural sciences in light of these observations.
• How do you see the ideas of Clay Shirky and Michael Nielson converging and diverging when looking at the future of the natural sciences? Mr. Nielson seems to be hopeful but guarded in his predictions of how open source sharing of scientific research could revolutionize the fields. Mr. Shirky is more of the opinion that the revolution has happened and now we need to catch up or be left behind. Could this be true for the sciences as well? What do you see as the future for the scientific fields you discussed in our paper in light of the opinions of these authors?

 

"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"